z-logo
Premium
The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment
Author(s) -
Califf Robert M.,
Kramer Judith M.
Publication year - 2008
Publication title -
pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.023
H-Index - 96
eISSN - 1099-1557
pISSN - 1053-8569
DOI - 10.1002/pds.1617
Subject(s) - medicine , library science , family medicine , computer science

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom